09/11/2025
Rapid-eye-movement sleep behaviour disorder (RBD) is a parasomnia causing motor behaviours and vocalizations during sleep, which can lead to injuries in patients and their bed partners. Adult-onset RBD generally precedes a neurodegenerative synucleinopathy, while other cases can be associated with antidepressant use, neurotrauma and narcolepsy.
The symptomatic treatment of RBD should encompass a full clinical assessment in which contributing factors should systemically be evaluated (antidepressants, obstructive sleep apnea, etc.). The evaluation and treatment paradigm should preferably include the patient, bed partner, and family/caregiver.
Despite the rapidly increasing knowledge about RBD, effective symptomatic treatment of RBD remains a significant challenge. The diagnosis of RBD is frequently delayed. Physicians and health care providers are frequently not familiar with this disorder. Once diagnosed, treatment options are limited and may be associated with adverse effects that limit their use.
This paper summarises the evidence supporting the use of clonazepam, melatonin, rivastigmine, and pramipexole, the four agents currently recommended by the American Academy of Sleep Medicine.
https://www.sciencedirect.com/science/article/abs/pii/S1389945725002291?via%3Dihub